Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Thursday's market session ended on a positive note, with the Dow Jones climbing over 150 points and investor sentiment leaning optimistic.
Accenture $ACN report a strong Q1 earnings. The consulting and technology giant posted GAAP earnings of $3.59 per share, beating estimates by $0.20. Revenue wasn’t just good—it was phenomenal—hitting $17.7 billion, a solid $570 million above expectations. What’s driving this success? A boom in demand for generative AI services, which also pushed new bookings to $18.7 billion, well above last year’s numbers. On top of that, Accenture raised its fiscal 2025 revenue outlook, signaling even more confidence in the road ahead.
But it wasn’t all sunshine. While the revenue beat was impressive, the company’s decision to lower its earnings forecast has some analysts raising eyebrows. Can Accenture keep its growth momentum alive as macroeconomic challenges pile up? That’s the big question. Meanwhile, related companies like Infosys $INFY and Wipro $WIT rode the wave, with their ADRs jumping nearly 3% on the positive sentiment stemming from Accenture’s results.
FedEx $FDX also made waves with a bold announcement. it’s spinning off its freight division. The logistics powerhouse delivered mixed Q2 results, with non-GAAP EPS of $4.05 beating estimates by $0.12, but revenue came in at $22 billion, slightly below expectations. Despite the revenue miss, investors were encouraged by the freight spin-off news, which is aimed at improving operational efficiency. The company also revised its fiscal 2025 outlook, reflecting ongoing economic pressures, but that didn’t stop $FDX from rallying in after-hours trading.
Nike $NKE and United States Steel $X caught some after-hours attention. Nike is riding some mixed sentiment following its latest earnings, while United States Steel continued to see steady interest as part of Thursday’s broader market buzz.
Yesterday at 01:40
The market saw remarkable performances this week as several companies made significant headlines, pushing their stock prices to new heights. Here’s a look at the top gainers, what fueled their meteoric rise, and a deeper dive into their prospects.
Aadi Bioscience Read More
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.